A neurotoxic alcohol exposure paradigm does not induce hepatic encephalopathy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27268733)

Published in Neurotoxicol Teratol on June 04, 2016

Authors

Joel G Hashimoto1, Kristine M Wiren1, Clare J Wilhelm2

Author Affiliations

1: Research & Development Service, VA Portland Health Care System, Portland, OR, USA; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
2: Research & Development Service, VA Portland Health Care System, Portland, OR, USA; Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA. Electronic address: wilhelmc@ohsu.edu.

Articles cited by this

Alcoholic hepatitis. N Engl J Med (2009) 4.98

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry (2015) 4.09

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 3.97

Metabolism and functions of glutathione in brain. Prog Neurobiol (2000) 3.74

Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia (1975) 2.25

EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS. J Clin Invest (1965) 2.05

Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol (1999) 1.92

Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J Leukoc Biol (2005) 1.77

Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med (2008) 1.55

Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit Care Med (2013) 1.52

NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J Neuroinflammation (2012) 1.49

Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology (1997) 1.48

Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology (1986) 1.48

Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction (2013) 1.48

Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect (2005) 1.41

Vapor inhalation of alcohol in rats. Curr Protoc Neurosci (2008) 1.37

Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry (1999) 1.25

Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes. J Neurochem (1995) 1.21

Ethanol withdrawal in mice bred to be genetically prone or resistant to ethanol withdrawal seizures. J Pharmacol Exp Ther (1986) 1.10

Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation. Alcohol Clin Exp Res (2004) 1.09

Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity. Neuropsychopharmacology (2007) 1.09

Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol (2009) 1.08

Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals. Endocrinology (2004) 1.07

Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275. J Am Coll Nutr (1995) 1.06

Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res (1986) 1.06

Animal models in alcohol research. Alcohol Res Health (2000) 1.03

Amelioration of ethanol-induced neurotoxicity in the neonatal rat central nervous system by antioxidant therapy. Alcohol Clin Exp Res (2000) 1.01

Excess mortality of alcohol-dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence. Alcohol Clin Exp Res (2012) 0.98

Alcoholism: a systemic proinflammatory condition. World J Gastroenterol (2014) 0.96

Effect of pyrazole on the induction of fatty liver by chronic administration of ethanol. Biochem Pharmacol (1972) 0.90

Alcohol and gamma-glutamyltransferase. Klin Wochenschr (1983) 0.89

Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol. Psychopharmacology (Berl) (2012) 0.88

Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol (2011) 0.87

Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal. Genes Brain Behav (2006) 0.87

Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J Neuroinflammation (2014) 0.84

Understanding the addiction cycle: a complex biology with distinct contributions of genotype vs. sex at each stage. Neuroscience (2014) 0.81

Defining a relationship between dietary fatty acids and the cytochrome P450 system in a mouse model of fatty liver disease. Physiol Genomics (2010) 0.81

Astrocyte Dysfunction Induced by Alcohol in Females but Not Males. Brain Pathol (2015) 0.80

Identification of neuroendocrine-specific protein as an ethanol-regulated gene with mRNA differential display. Mamm Genome (1998) 0.80

Females uniquely vulnerable to alcohol-induced neurotoxicity show altered glucocorticoid signaling. Brain Res (2015) 0.79